Top 6 Things to Know About the $30 Billion Sleep Aids Market

As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. Plus, stress in 2020 related to the presidential election, Covid-19 pandemic and recession are all contributing to more sleepless nights.

Topics: House & Home Pharmaceuticals Medical Devices Industry Insights

Winners and Losers in the Consumer Goods Industry During Q4-2020

International trade data can represent an accurate barometer of the state of the health of the global economy, even more so in the current extraordinary circumstances, that require up-to-date monitoring for companies involved in international business.

Topics: Food & Beverage House & Home Retail Apparel Pharmaceuticals Healthcare Industry Insights

U.S. Weight Loss Industry Struggles in 2020, but Commercial Chains Survive Pandemic

The total U.S. weight loss market hit a new peak in 2019, growing to $78 billion. However, that growth came to a halt when the coronavirus hit last March, shutting the doors of many weight loss centers, doctors’ offices, clinics, and other businesses for 8–10 weeks. As a result, the market’s value is estimated to have fallen by 21%.
Topics: Food & Beverage Pharmaceuticals Healthcare

COVID-19 Vaccines: The Blockbuster Drugs of 2021

For the pharmaceutical industry and the broader scientific community, creating and producing effective COVID-19 vaccines has been a challenge and opportunity of a lifetime — a chance to help save humanity from an urgent global crisis.

Topics: Pharmaceuticals Industry Insights

$2 Billion U.S. Autism Treatment Market Is Poised for Growth Next Year

There are 3.5 million children and adults with autism in America. The North American market for autism disorder treatment is expected to grow over the next five years, due to a variety of factors:
Topics: Pharmaceuticals Healthcare Industry Insights

The Coronavirus’ Effect on the Health Care Industry

The Coronavirus pandemic created new risks for patients and care givers alike. Significant new safety practices and costs will be standard for years to come—perhaps forever, as we seek to eliminate the spread of the Coronavirus as well as any future viral threats.

Topics: Pharmaceuticals Healthcare Industry Insights

The Growing Market for Chronic Lower Back Pain (CLBP)

Chronic lower back pain (CLBP) is the second leading cause of disability worldwide. The prevalence of CLBP in adults has grown significantly over the last ten years.

Topics: Pharmaceuticals Healthcare Industry Insights

The State of the Medical Marijuana Market in 2020

Cannabis culture is not new and is not restricted to recreational purposes. The use of cannabis, a.k.a. marijuana, for medicinal purposes such as joint pain, muscle spasms, gout, spinal cord injury, and insomnia, dates back to as early as 5000 BC.

Topics: Pharmaceuticals Industry Insights

Infographic: Non-Small Cell Lung Cancer (NSCLC) Market Insights

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounted for around 85% of all lung cancers in the United States.

Topics: Pharmaceuticals Industry Insights

$71 Billion U.S. Weight Loss Industry Pivots to Survive Pandemic

The total U.S. weight loss market hit a new peak in 2019, growing to $78 billion. However, that growth came to a halt when the Coronavirus hit in March, shutting the doors of weight loss centers, doctors’ offices, clinics, and other businesses for 8-10 weeks. As a result, the value of the market is forecast to decline by 9% this year.

Topics: Food & Beverage Pharmaceuticals Healthcare Industry Insights